Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Accolade (ACCD)
NASDAQ:ACCD
ACCD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.08 - $11.71
Previous CloseN/A
Volume14.97M
Average Volume (3M)3.06M
Market Cap
$565.82M
Enterprise Value$323.71M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.44
Next Earnings
Apr 24, 2025EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.25
Shares Outstanding81,884,224
10 Day Avg. Volume1,338,584
30 Day Avg. Volume3,063,893
Standard Deviation0.26
R-Squared0.16
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.26
Price to Cash Flow (P/CF)-14.40
P/FCF Ratio0.00
Enterprise Value/Market Cap0.57
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.69
Enterprise Value/Ebitda-7.10
Forecast
1Y Price Target
$8.35Price Target Upside20.84% Upside
Rating ConsensusHold
Number of Analyst Covering11
---
Bulls Say, Bears Say
Bulls Say
AcquisitionThe acquisition by Transcarent represents a premium of approximately 110% compared to the previous closing price.
Strategic SynergyThe strategic acquisition is seen as logical and synergistic, enhancing AI capabilities in ACCD's operations.
Technology EnhancementTranscarent's technology and care coordination efforts can enhance Accolade's offerings, potentially leading to higher retention levels and revenue growth.
Bears Say
Guidance WithdrawalThe company is withdrawing its prior guidance for FY25 and will not host the previously scheduled call.
Market Rating DowngradeThe analyst downgrades ACCD to Market Perform due to the stock's run up towards the deal price and previous price target.
Revenue PerformanceTotal revenue of $105.1M was slightly below consensus estimates of $106M.
---
Ownership Overview
9.81% Insiders
11.65% Mutual Funds
31.85% Other Institutional Investors
34.76% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ACCD FAQ
What was Accolade’s price range in the past 12 months?
Accolade lowest stock price was $3.08 and its highest was $11.71 in the past 12 months.
What is Accolade’s market cap?
Accolade’s market cap is $565.82M.
When is Accolade’s upcoming earnings report date?
Accolade’s upcoming earnings report date is Apr 24, 2025 which is in 61 days.
How were Accolade’s earnings last quarter?
Accolade released its earnings results on Jan 09, 2025. The company reported -$1.5 earnings per share for the quarter, missing the consensus estimate of -$0.324 by -$1.176.
Is Accolade overvalued?
According to Wall Street analysts Accolade’s price is currently Undervalued.
Does Accolade pay dividends?
Accolade does not currently pay dividends.
What is Accolade’s EPS estimate?
Accolade’s EPS estimate is 0.05.
How many shares outstanding does Accolade have?
Accolade has 81,884,224 shares outstanding.
What happened to Accolade’s price movement after its last earnings report?
Accolade reported an EPS of -$1.5 in its last earnings report, missing expectations of -$0.324. Following the earnings report the stock price went up 1.763%.
Which hedge fund is a major shareholder of Accolade?
Currently, no hedge funds are holding shares in ACCD
---
Accolade Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$8.35 (20.84% Upside)
$8.35 (20.84% Upside)
Blogger Sentiment
Bullish
ACCD Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 718.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 4.0%
Last 30 Days ▼ 4.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-40.86%
12-Months-Change
Fundamentals
Return on Equity
-48.23%
Trailing 12-Months
Asset Growth
-17.57%
Trailing 12-Months
Company Description
Accolade
Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. it generates revenue through providing personalized health guidance solutions to members.
---
ACCD Company Deck
---
ACCD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Accolade reported strong revenue and cash flow performance, with significant new wins and a robust cash position. However, challenges include potential delays in health plan deployments and increased pressure from ROI guarantees.Read More>---
ACCD Stock 12 Month Forecast
Average Price Target
$8.35
▲(20.84% Upside)
Technical Analysis
Best Analysts Covering ACCD
1 Year
1 Year Success Rate
4/5 ratings generated profit
1 Year Average Return
+55.12%
reiterated a buy rating 5 months ago
Copying Allen Lutz's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +55.12% per trade.
---